Genetic Variability in CYP2D6 in U.S Active Duty Population

NCT02960568 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

550

Enrollment

FED

Sponsor class

Conditions

Pharmacologic Action

Interventions

DRUG: Primaquine

Sponsor

Walter Reed Army Institute of Research (WRAIR)